Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproheptadine for prevention of delirium in critically ill patients
IRCT201312203449N13Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cyproheptadine in delirium, sponsored by Tehran University of Medical Sciences. Started Oct 2013; status: completed.
02
Drugs
cyproheptadine
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT201312203449N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201312203449N13.